Michael W. Rogers's Trading History
| AKBAAkebia Therapeutics | Jun 22, 2026 | Director | Uninformative Buy | ― | $139.38K | |
| EYPTEyePoint Pharmaceuticals | Jun 24, 2019 | Director | Uninformative Buy | 11.00K | $41.47K | |
| KERXKeryx Biopharma | Dec 13, 2018 | ― | Uninformative Sell | ― | $0.00 | |
| ACORQAcorda Therapeutics | Dec 03, 2015 | ― | Uninformative Sell | 36.68K | $529.27 | |
| BGMDBG Medicine | ― | EVP, CFO & Treas | ― | ― | ||
| WHWKWhitehawk Therapeutics | ― | Chief Financial and Chief Business Officer | ― | ― | ||
| ARAVAravive | ― | ― | ― | ― |
You May Also Like
Michael W. Rogers insider profile FAQ
What stocks does Michael W. Rogers hold?
Michael W. Rogers holds: AKBA, ACORQ, KERX, ARAV, WHWK, EYPT, BGMD stocks.
What is Michael W. Rogers's role in Akebia Therapeutics?
Michael W. Rogers's role in Akebia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.